AIIMS Delhi Gives 30-year-old Man 1st Dose of Bharat Biotech's Potential Coronavirus Vaccine - Covaxin

The All India Institute of Medical Sciences ( AIIMS ), New Delhi has administered its first dose of Bharat Biotech's 'Covaxin' to a 30 year old man on Friday.  The development comes days after the ethics committee gave approval to AIIMS, Delhi to begin human trails of the potential Covid-19 vaccine..

The next dose of the medicine will be given to the subject after a period of two weeks during which he will be monitored.  AIIMS, Delhi is one of the 12 sites selected by ICMR for conducting the Phase-I and II randomized, double-blind and placebo controlled clinical trials of Covaxin. 

Dr. Sanjay Rai, who is the principal investigator of Cvid-19 vaccine trails at AIIMS told that the first dose of 0.5 ml of the intramuscular vaccine was given to the subject on Friday and the person was observed for 2 hours.  Dr. Rai also said that a diary was given to him to constantly monitor his conditions and make observations.  The medical team would coordinate with the person daily for a week to understand if he encounters any medical issues,

The phase I and II clinical trials of the vaccine for SARS-CoV-2 by Bharat Biotech have been approved by the Indian drug regulator after pre-clinical studies demonstrated safety and immune response.

The company has developed the vaccine in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV).

For more details please click here